Literature DB >> 12140616

Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients.

Kiyoaki Ouchi1, Junichi Mikuni, Yoichiro Kakugawa.   

Abstract

BACKGROUND/
PURPOSE: The long-term effects of initial laparoscopic cholecystectomy on the prognosis of patients with GBC remain unknown because of the limited numbers of patients reported from single institutions. This study was designed to determine the long-term prognosis of patients with gallbladder carcinoma (GBC) who had undergone laparoscopic cholecystectomy (LC), and to clarify the role of LC for the treatment of GBC and the benefit of aggressive additional excision.
METHODS: The clinical courses and outcomes of 498 patients with laparoscopically removed GBC registered in a nationwide survey were examined. Written questionnaires sent to members of the Japanese Society of Biliary Surgery included questions on Preoperative diagnosis, timing and methods to obtain final diagnosis, depth of invasion, second surgical procedure, prognosis of patients, and type of recurrence, if any.
RESULTS: The 5-year survival rates of patients after LC according to the depth of invasion were as follows: 99% in those with pT1a (limited to the mucosa), 95% in those with pT1b (muscularis), 70% in those with pT2 (subserosa), 20% in those with pT3 (serosa), and 0% in those with pT4 (serosa with invasion to adjacent organs). Perforation of the gallbladder during LC was found in 20% of the patients. Patients with gallbladders perforated during LC showed a significantly lower survival rate than did those without perforated gallbladders ( P < 0.01). Additional excision during or after LC was carried out in 48% of the patients, and the frequency of additional excision increased in accordance with the depth of invasion. Compared with patients who underwent LC only, additional excision resulted in better survival in patients with pT2 or pT3 tumors ( P = 0.051 and P < 0.05, respectively), but this difference was not found in patients with pT1 or pT4 tumors.
CONCLUSIONS: LC is not likely to worsen the survival rate of patients with GBC compared with the survival rate of patients undergoing a standard open radical procedure, as long as additional excision is conducted for patients with laparoscopically removed pT2 or pT3 GBCs. Special attention should be paid to prevention of bile spillage during LC.

Entities:  

Mesh:

Year:  2002        PMID: 12140616     DOI: 10.1007/s005340200028

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  46 in total

Review 1.  Gallbladder cancer.

Authors:  Mislav Rakić; Leonardo Patrlj; Mario Kopljar; Robert Kliček; Marijan Kolovrat; Bozo Loncar; Zeljko Busic
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Gallbladder cancer: the basics.

Authors:  Eldon A Shaffer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

3.  Long-term outcomes of incidental gallbladder carcinoma without additional resection: A single institution experiment.

Authors:  Tomohiro Sugiyama; Kenta Makino; Yukiko Fukui; Hiromitsu Kinoshita; Akira Miki; Shigeki Uchida; Michihiko Tsubono; Yasushi Adachi
Journal:  Mol Clin Oncol       Date:  2020-06-02

4.  Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2010-02-23       Impact factor: 4.584

5.  Unexpected identification of gallbladder carcinoma during cholecystectomy.

Authors:  Charles M Vollmer
Journal:  J Gastrointest Surg       Date:  2009-02-24       Impact factor: 3.452

6.  Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer.

Authors:  Dong Hyun Kim; Sung Hoon Kim; Gi Hong Choi; Chang Moo Kang; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

7.  Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group.

Authors:  Ryusei Matsuyama; Kenichi Matsuo; Ryutaro Mori; Mitsutaka Sugita; Naotaka Yamaguchi; Toru Kubota; Kunio Kameda; Yasuhisa Mochizuki; Ryo Takagawa; Toshiaki Kadokura; Goro Matsuda; Noriyuki Kamiya; Itaru Endo
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

8.  Delayed laparoscopic subtotal cholecystectomy in acute cholecystitis with severe fibrotic adhesions.

Authors:  Atsushi Horiuchi; Yuji Watanabe; Takashi Doi; Kouichi Sato; Shungo Yukumi; Motohira Yoshida; Yuji Yamamoto; Hiroki Sugishita; Kanji Kawachi
Journal:  Surg Endosc       Date:  2008-04-04       Impact factor: 4.584

Review 9.  Evidence-based clinical practice guidelines for cholelithiasis 2016.

Authors:  Susumu Tazuma; Michiaki Unno; Yoshinori Igarashi; Kazuo Inui; Kazuhisa Uchiyama; Masahiro Kai; Toshio Tsuyuguchi; Hiroyuki Maguchi; Toshiyuki Mori; Koji Yamaguchi; Shomei Ryozawa; Yuji Nimura; Naotaka Fujita; Keiichi Kubota; Junichi Shoda; Masami Tabata; Tetsuya Mine; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-12-10       Impact factor: 7.527

10.  A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.

Authors:  Dai Mohri; Hideaki Ijichi; Koji Miyabayashi; Ryota Takahashi; Yotaro Kudo; Takashi Sasaki; Yoshinari Asaoka; Yasuo Tanaka; Tsuneo Ikenoue; Keisuke Tateishi; Minoru Tada; Hiroyuki Isayama; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2015-11-27       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.